Castle Biosciences Reports Fourth Quarter and Full-Year 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St climbs after Fed's Waller says he could support rate hold
- Fed’s Waller open to September rate hold - if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
Castle Biosciences Inc. (CSTL) Tops Q4 EPS by 22c
February 28, 2022 4:14 PM ESTCastle Biosciences Inc. (NASDAQ: CSTL) reported Q4 EPS of ($0.25), $0.22 better than the analyst estimate of ($0.47). Revenue for the quarter came in at $25 million versus the consensus estimate of $23.73 million.
GUIDANCE:
Castle Biosciences Inc. sees FY2022 revenue of $115-120... More
